140 related articles for article (PubMed ID: 36739767)
1. Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.
Jauvin D; Pierre M; Boutjdir M; Puymirat J; Chahine M
Stem Cell Res; 2023 Mar; 67():103037. PubMed ID: 36739767
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
Chahine M; Jauvin D; Pierre M; Puymirat J; Boutjdir M
Stem Cell Res; 2023 Sep; 71():103148. PubMed ID: 37352653
[TBL] [Abstract][Full Text] [Related]
3. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
Martineau L; Racine V; Benichou SA; Puymirat J
Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (ZZUi015-A) from a DM1 patient with cataract.
Li T; Sun H; Wang Z; Zhang Q; Chen N; Zhang K; Wang Y; Xu Y
Stem Cell Res; 2022 Jan; 58():102623. PubMed ID: 34915310
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010-A and CBRCULi011-A).
De Serres-Bérard T; Jauvin D; Puymirat J; Chahine M
Stem Cell Res; 2023 Oct; 72():103234. PubMed ID: 37871474
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
Azotla-Vilchis CN; Sanchez-Celis D; Agonizantes-Juárez LE; Suárez-Sánchez R; Hernández-Hernández JM; Peña J; Vázquez-Santillán K; Leyva-García N; Ortega A; Maldonado V; Rangel C; Magaña JJ; Cisneros B; Hernández-Hernández O
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530452
[TBL] [Abstract][Full Text] [Related]
7. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
[TBL] [Abstract][Full Text] [Related]
8. Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1.
Nguyen CDL; Jimenez-Moreno AC; Merker M; Bowers CJ; Nikolenko N; Hentschel A; Müntefering T; Isham A; Ruck T; Vorgerd M; Dobelmann V; Gourdon G; Schara-Schmidt U; Gangfuss A; Schröder C; Sickmann A; Gross C; Gorman G; Stenzel W; Kollipara L; Hathazi D; Spendiff S; Gagnon C; Preusse C; Duchesne E; Lochmüller H; Roos A
J Neurol; 2023 Jun; 270(6):3138-3158. PubMed ID: 36892629
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial effects of ion channel mis-splicing as a cause of myopathy in myotonic dystrophy.
Nitschke L; Cooper TA
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 38165037
[TBL] [Abstract][Full Text] [Related]
10. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
11. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.
Overend G; Légaré C; Mathieu J; Bouchard L; Gagnon C; Monckton DG
Hum Mol Genet; 2019 Jul; 28(13):2245-2254. PubMed ID: 31220271
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing.
Franck S; Couvreu De Deckersberg E; Bubenik JL; Markouli C; Barbé L; Allemeersch J; Hilven P; Duqué G; Swanson MS; Gheldof A; Spits C; Sermon KD
Biol Open; 2022 Jan; 11(1):. PubMed ID: 35019138
[TBL] [Abstract][Full Text] [Related]
13. Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of
Hildonen M; Knak KL; Dunø M; Vissing J; Tümer Z
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823742
[TBL] [Abstract][Full Text] [Related]
14. Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center.
Mazzoli M; Ariatti A; Garuti GC; Agnoletto V; Genovese M; Gozzi M; Kaleci S; Marchioni A; Malagoli M; Galassi G
Acta Myol; 2020 Sep; 39(3):109-120. PubMed ID: 33305167
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.
Dastidar S; Majumdar D; Tipanee J; Singh K; Klein AF; Furling D; Chuah MK; VandenDriessche T
Mol Ther; 2022 Jan; 30(1):75-91. PubMed ID: 34371182
[TBL] [Abstract][Full Text] [Related]
17. Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.
Izzo M; Battistini J; Provenzano C; Martelli F; Cardinali B; Falcone G
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563013
[TBL] [Abstract][Full Text] [Related]
18. Reduced renal function in patients with Myotonic Dystrophy type 1 and the association to CTG expansion and other potential risk factors for chronic kidney disease.
Aldenbratt A; Lindberg C; Svensson MK
Neuromuscul Disord; 2017 Nov; 27(11):1038-1042. PubMed ID: 29029879
[TBL] [Abstract][Full Text] [Related]
19. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of congenital myotonic dystrophy.
Lanni S; Pearson CE
Neurobiol Dis; 2019 Dec; 132():104533. PubMed ID: 31326502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
